Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Enliven Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Skye Bioscience Inc. May 26, 202697.8%
-
CAMP4 Therapeutics Corporation June 11, 202596.1%
-
Skye Bioscience Inc. June 6, 202589.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Skye Bioscience Inc. | Open-market sale | −114,851 | $1.61 | $184,910 |
| Sep 23, 2026 | Skye Bioscience Inc. | Open-market sale | −4,528 | $1.61 | $7,290 |
| Sep 22, 2026 | Skye Bioscience Inc. | Open-market sale | −27,612 | $1.65 | $45,560 |
| Sep 22, 2026 | Skye Bioscience Inc. | Open-market sale | −1,088 | $1.65 | $1,795 |
| Sep 16, 2026 | Skye Bioscience Inc. | Open-market sale | −32,607 | $1.91 | $62,279 |
| Sep 16, 2026 | Skye Bioscience Inc. | Open-market sale | −1,285 | $1.91 | $2,454 |
| Aug 27, 2026 | CAMP4 Therapeutics Corporation | Open-market sale | −400,000 | $4.04 | $1,616,000 |
| Aug 24, 2026 | CAMP4 Therapeutics Corporation | Open-market sale | −10 | $4.50 | $45 |
| Aug 21, 2026 | CAMP4 Therapeutics Corporation | Open-market sale | −32,018 | $4.50 | $144,081 |
| Aug 20, 2026 | CAMP4 Therapeutics Corporation | Open-market sale | −114,700 | $4.54 | $520,738 |
| Aug 20, 2026 | Skye Bioscience Inc. | Open-market sale | −1,159 | $0.32 | $371 |
| Aug 20, 2026 | Skye Bioscience Inc. | Open-market sale | −46 | $0.32 | $15 |
| Aug 20, 2026 | Skye Bioscience Inc. | Open-market sale | −6,495 | $0.32 | $2,078 |
| Aug 19, 2026 | CAMP4 Therapeutics Corporation | Open-market sale | −45,147 | $4.76 | $214,900 |
| Aug 19, 2026 | Skye Bioscience Inc. | Open-market sale | −10,255 | $0.35 | $3,589 |
Questions about Andrew J. Schwab
What boards is Andrew J. Schwab on?
Andrew J. Schwab sits on the boards of CAMP4 Therapeutics Corporation, Enliven Therapeutics Inc. and Skye Bioscience Inc.
How long has Andrew J. Schwab served on boards?
Our records show at least 9 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.